CorMedix (CRMD) Enterprise Value (2016 - 2025)
Historic Enterprise Value for CorMedix (CRMD) over the last 14 years, with Q3 2025 value amounting to -$56.6 million.
- CorMedix's Enterprise Value fell 2292.93% to -$56.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$56.6 million, marking a year-over-year decrease of 2292.93%. This contributed to the annual value of -$51.7 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, CorMedix's Enterprise Value is -$56.6 million, which was down 2292.93% from -$190.7 million recorded in Q2 2025.
- CorMedix's 5-year Enterprise Value high stood at -$45.6 million for Q2 2024, and its period low was -$190.7 million during Q2 2025.
- Its 5-year average for Enterprise Value is -$70.1 million, with a median of -$60.3 million in 2022.
- In the last 5 years, CorMedix's Enterprise Value soared by 4684.0% in 2024 and then tumbled by 31813.33% in 2025.
- Quarter analysis of 5 years shows CorMedix's Enterprise Value stood at -$65.5 million in 2021, then grew by 10.19% to -$58.8 million in 2022, then crashed by 47.28% to -$86.6 million in 2023, then soared by 40.31% to -$51.7 million in 2024, then fell by 9.47% to -$56.6 million in 2025.
- Its last three reported values are -$56.6 million in Q3 2025, -$190.7 million for Q2 2025, and -$77.5 million during Q1 2025.